LivaNova sponsored and funded the studies in ... The population studied “was probably the sickest group of treatment-resistant depression patients ever studied,” said Conway, who was also ...

Learn more about whether iRhythm Technologies, Inc. or LivaNova PLC is a better investment based on AAII's A+ Investor grades ...

Learn more about whether Integer Holdings Corporation or LivaNova PLC is a better investment based on AAII's A+ Investor ...

LivaNova (LIVN – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Michael Matson from ...

LivaNova’s LIVN OSPREY trial, evaluating the aura6000 nerve stimulation system for obstructive sleep apnea (OSA), has delivered promising results.By meeting primary safety and efficacy endpoints ...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its fourth-quarter and full-year 2024 results on Tuesday, February 25, 2025 at 1 p.m.

Therapeutic breakthroughs in neuromodulation merge wearable technologies, deep brain implants, and tailored stimulations ...

LONDON, January 21, 2025--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its fourth-quarter and full-year 2024 results on Tuesday ...